Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee
- PMID: 20068560
- DOI: 10.1038/ajg.2009.727
Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee
Erratum in
- Am J Gastroenterol. 2010 Mar;105(3):500
Abstract
Guidelines for clinical practice are aimed to indicate preferred approaches to medical problems as established by scientifically valid research. Double-blind placebo controlled studies are preferable, but compassionate-use reports and expert review articles are used in a thorough review of the literature conducted through Medline with the National Library of Medicine. When only data that will not withstand objective scrutiny are available, a recommendation is identified as a consensus of experts. Guidelines are applicable to all physicians who address the subject regardless of specialty training or interests and are aimed to indicate the preferable but not necessarily the only acceptable approach to a specific problem. Guidelines are intended to be flexible and must be distinguished from standards of care, which are inflexible and rarely violated. Given the wide range of specifics in any health-care problem, the physician must always choose the course best suited to the individual patient and the variables in existence at the moment of decision. Guidelines are developed under the auspices of the American College of Gastroenterology and its Practice Parameters Committee and approved by the board of trustees. Each has been intensely reviewed and revised by the Committee, other experts in the field, physicians who will use them, and specialists in the science of decision analysis. The recommendations of each guideline are therefore considered valid at the time of composition based on the data available. New developments in medical research and practice pertinent to each guideline will be reviewed at a time established and indicated at publication to assure continued validity. The recommendations made are based on the level of evidence found. Grade A recommendations imply that there is consistent level 1 evidence (randomized controlled trials), grade B indicates that the evidence would be level 2 or 3, which are cohort studies or case-control studies. Grade C recommendations are based on level 4 studies, meaning case series or poor-quality cohort studies, and grade D recommendations are based on level 5 evidence, meaning expert opinion.
Similar articles
-
Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee.Am J Gastroenterol. 2004 Jul;99(7):1371-85. doi: 10.1111/j.1572-0241.2004.40036.x. Am J Gastroenterol. 2004. PMID: 15233681
-
Ulcerative colitis practice guidelines in adults. American College of Gastroenterology, Practice Parameters Committee.Am J Gastroenterol. 1997 Feb;92(2):204-11. Am J Gastroenterol. 1997. PMID: 9040192 Review.
-
Management of primary sclerosing cholangitis.Am J Gastroenterol. 2002 Mar;97(3):528-34. doi: 10.1111/j.1572-0241.2002.05585.x. Am J Gastroenterol. 2002. PMID: 11922543 Review.
-
Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. American College of Gastroenterology Practice Parameters Committee.Am J Gastroenterol. 1997 Jul;92(7):1081-91. Am J Gastroenterol. 1997. PMID: 9219775 Review.
-
Management of Crohn's disease in adults.Am J Gastroenterol. 2009 Feb;104(2):465-83; quiz 464, 484. doi: 10.1038/ajg.2008.168. Epub 2009 Jan 6. Am J Gastroenterol. 2009. PMID: 19174807
Cited by
-
Chromoendoscopy with targeted biopsies is superior to white-light endoscopy for the long-term follow-up detection of dysplasia in ulcerative colitis patients: a multicenter randomized-controlled trial.Gastroenterol Rep (Oxf). 2020 Sep 20;9(1):14-21. doi: 10.1093/gastro/goaa028. eCollection 2021 Jan. Gastroenterol Rep (Oxf). 2020. PMID: 33747522 Free PMC article.
-
Management of Inflammatory Bowel Disease in the Elderly.Curr Treat Options Gastroenterol. 2016 Sep;14(3):285-304. doi: 10.1007/s11938-016-0099-6. Curr Treat Options Gastroenterol. 2016. PMID: 27387455 Review.
-
An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease.Sci Transl Med. 2015 Aug 12;7(300):300ra128. doi: 10.1126/scitranslmed.aaa5657. Sci Transl Med. 2015. PMID: 26268315 Free PMC article.
-
Clinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ulcerative Colitis.J Crohns Colitis. 2016 Nov;10(11):1294-1302. doi: 10.1093/ecco-jcc/jjw103. Epub 2016 May 20. J Crohns Colitis. 2016. PMID: 27208386 Free PMC article. Clinical Trial.
-
Efficacy and safety of tofacitinib dose de-escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open.Aliment Pharmacol Ther. 2020 Jan;51(2):271-280. doi: 10.1111/apt.15555. Epub 2019 Oct 29. Aliment Pharmacol Ther. 2020. PMID: 31660640 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical